Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson’s disease patients: a prospective longitudinal study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1590-3478
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson’s disease patients: a prospective longitudinal study ; day:24 ; month:5 ; year:2021 ; pages:1-8
Neurological sciences ; (24.5.2021), 1-8
- Creator
-
De Micco, Rosa
Satolli, Sara
Siciliano, Mattia
De Mase, Antonio
Giordano, Alfonso
Tedeschi, Gioacchino
Tessitore, Alessandro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10072-021-05324-w
- URN
-
urn:nbn:de:101:1-2021092022264622278881
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- De Micco, Rosa
- Satolli, Sara
- Siciliano, Mattia
- De Mase, Antonio
- Giordano, Alfonso
- Tedeschi, Gioacchino
- Tessitore, Alessandro
- SpringerLink (Online service)
Other Objects (12)
Drooling in Parkinson’s Disease: Prevalence and Progression from the Non-motor International Longitudinal Study
Gender differences in non-motor fluctuations in Parkinson’s disease
Non-motor symptoms in newly diagnosed Parkinson’s disease patients
Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study
Behavioral characterization of the 6-hydroxidopamine model of Parkinson’s disease and pharmacological rescuing of non-motor deficits
Screening for non-motor symptoms in Egyptian patients with Parkinson’s disease
NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease
A longitudinal study on the effects of COVID-19 pandemic on non-motor symptoms in Parkinson’s disease
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
Microstructure predicts non-motor outcomes following deep brain stimulation in Parkinson’s disease
Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease
Are we missing non-motor seizures in Parkinson’s disease? Two case reports
Drooling in Parkinson’s Disease: Prevalence and Progression from the Non-motor International Longitudinal Study
Gender differences in non-motor fluctuations in Parkinson’s disease
Non-motor symptoms in newly diagnosed Parkinson’s disease patients
Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study
Behavioral characterization of the 6-hydroxidopamine model of Parkinson’s disease and pharmacological rescuing of non-motor deficits
Screening for non-motor symptoms in Egyptian patients with Parkinson’s disease
NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease
A longitudinal study on the effects of COVID-19 pandemic on non-motor symptoms in Parkinson’s disease
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
Microstructure predicts non-motor outcomes following deep brain stimulation in Parkinson’s disease
Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease
Are we missing non-motor seizures in Parkinson’s disease? Two case reports
Drooling in Parkinson’s Disease: Prevalence and Progression from the Non-motor International Longitudinal Study
Gender differences in non-motor fluctuations in Parkinson’s disease
Non-motor symptoms in newly diagnosed Parkinson’s disease patients
Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study
Behavioral characterization of the 6-hydroxidopamine model of Parkinson’s disease and pharmacological rescuing of non-motor deficits
Screening for non-motor symptoms in Egyptian patients with Parkinson’s disease
NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease
A longitudinal study on the effects of COVID-19 pandemic on non-motor symptoms in Parkinson’s disease
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
Microstructure predicts non-motor outcomes following deep brain stimulation in Parkinson’s disease
Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease